









Markets
/
Stocks
/
nasdaq-sxtpw
/

60 Degrees Pharmaceuticals Inc

SXTPW

View Detailed Chart

0.052USD

+0.016+46.46%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

0.00Market Cap

--P/E TTM



60 Degrees Pharmaceuticals Inc

0.052

+0.016+46.46%

Overview Company Financials

Financials

Intraday

30m

Today

+46.46%

5 Days

+16.18%

1 Month

+Infinity%

6 Months

+36.05%

Year to Date

+74.07%

1 Year

+26.10%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(2)

Buy(7)

Indicators

Sell(2)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.008

Neutral

RSI(14)

43.239

Neutral

STOCH(KDJ)(9,3,3)

22.043

Sell

ATR(14)

0.035

High Vlolatility

CCI(14)

-202.388

Oversold

Williams %R

100.000

Oversold

TRIX(12,20)

1.399

Buy

StochRSI(14)

0.000

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

0.036

Buy

MA10

0.043

Buy

MA20

0.045

Buy

MA50

0.035

Buy

MA100

0.033

Buy

MA200

0.026

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.

Ticker SymbolSXTPW

Company60 Degrees Pharmaceuticals Inc

CEODr. Ll S. Dow, Ph.D.

Websitehttps://60degreespharma.com/